PvP Biologics
Facts
- HQ
- Seattle, Washington, USA
- Sectors
- Biotech
- Stage
- Acquired
Is this your organization? Claim it
Nobel Laureate David Baker Secures $7M from Washington Research Foundation for AI-Designed Protein Program at UW
Nobel Laureate David Baker received $7 million from the Washington Research Foundation to advance AI-designed protein research at the University of Washington. The initiative aims to develop designer enzymes for medicine, technology, and sustainability while fostering new scientists and startups.
Nobel Laureate David Baker Drives Protein Design Innovation and Startup Growth at University of Washington
David Baker, Nobel Prize winner and head of the Institute for Protein Design at the University of Washington, is focused on advancing protein design research and entrepreneurship, having helped spawn over 20 startups in Seattle's biotech hub. He plans to continue accelerating scientific innovation in the field, which develops new proteins for therapeutics, vaccines, and materials.
Xaira Therapeutics Launches Seattle AI Biotech Startup with $1B to Innovate Protein-Based Drug Discovery
Xaira Therapeutics, an AI-driven biotech startup founded in April with over $1 billion in investment, aims to revolutionize drug discovery using protein design technologies developed at the University of Washington’s Institute for Protein Design. Led by Hetu Kamisetty in Seattle, the company integrates AI models like RFDiffusion and ProteinMPNN to create new protein-based therapeutics, tapping into the growing market of biologics that accounted for a third of drug approvals in 2022.
See all 13 stories, episodes and videos about PvP Biologics.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events